Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,131Revenue $M2.6Net Margin (%)0Z-Score68.0
Enterprise Value $M1,000EPS $-0.6Operating Margin %0F-Score4
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)0Higher ROA y-yY
Price/Book8.910-y EBITDA Growth Rate %-37.3Quick Ratio14.5Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-6.5Current Ratio14.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-36.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-38.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M96.8ROI % (ttm)-50.2Gross Margin Increase y-yN

Gurus Latest Trades with ACHN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ACHNJean-Marie Eveillard 2014-03-31 Sold Out -0.01%$3.08 - $4.2
($3.5)
$ 11.57231%Sold Out0
ACHNJean-Marie Eveillard 2013-12-31 Buy 0.01%$2.43 - $3.46
($2.9)
$ 11.57299%New holding, 600000 sh.600,000
ACHNJohn Burbank 2012-12-31 Sold Out -0.24%$7.2 - $11.1
($8.86)
$ 11.5731%Sold Out0
ACHNJohn Burbank 2012-09-30 Buy 0.24%$5.61 - $10.41
($7.06)
$ 11.5764%New holding, 500000 sh.500,000
ACHNGeorge Soros 2012-06-30 Sold Out -0.04%$5.94 - $10.95
($7.34)
$ 11.5758%Sold Out0
ACHNGeorge Soros 2012-03-31 Reduce-0.09%$7.71 - $12.375
($9.57)
$ 11.5721%Reduce -50%250,000
ACHNGeorge Soros 2011-12-31 Add0.16%$4.01 - $8
($6.15)
$ 11.5788%Add 2132.14%500,000
ACHNGeorge Soros 2011-09-30 Buy $4.63 - $8.31
($6.37)
$ 11.5782%New holding, 22400 sh.22,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ACHN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ACHN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
RA CAPITAL MANAGEMENT, LLC10% Owner 2014-08-27Sell2,711,352$11.331.06 view
Truitt JosephEVP, Chief Commercial Officer 2014-08-25Sell25,000$10.825.82 view
Deshpande MilindPresident and CEO 2014-08-18Sell216,624$1014.5 view
RA CAPITAL MANAGEMENT, LLC10% Owner 2014-08-18Sell4,235,000$9.5320.15 view
KISHBAUCH MICHAEL DDirector 2014-08-15Sell495,812$9.421.81 view
FRASHIER GARY EDirector 2014-08-13Sell5,000$843.13 view
RA CAPITAL MANAGEMENT, LLCSee Footnotes (1)(5) 2014-06-20Sell880,000$8.436.31 view
Truitt JosephEVP, Chief Commercial Officer 2014-06-16Sell25,000$7.8246.42 view
FRASHIER GARY EDirector 2014-06-16Sell55,000$843.13 view
FRASHIER GARY EDirector 2014-06-16Sell55,000$843.13 view

Press Releases about ACHN :

    Quarterly/Annual Reports about ACHN:

    News about ACHN:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Achillion Pharmaceutical Inc, Protective Life Corp, Host Hotels & Resort Aug 25 2014 
    Top 4 Insider Buys of Last Week Jun 10 2013 
    comment on ACHN Mar 15 2013 
    comment on ACHN Mar 09 2013 
    Achillion Will Surge If New Drug Is Successful Apr 21 2012 
    Weekly CEO Sells Highlight: Achillion Pharmaceuticals Inc, Monster Beverage Corp, CarMax Inc, and Im Jan 23 2012 
    Weekly CEO Sells Highlight: UNH, LRY, ACHN, RPM Jan 16 2012 
    Achillion Pharmaceuticals Inc. Reports Operating Results (10-Q) Oct 27 2010 
    Achillion Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
    Achillion Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 03 2009 


    More From Other Websites
    Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As Aug 27 2014
    The Zacks Analyst Blog Highlights: Roche, InterMune, Achillion Pharmaceuticals, Puma Biotechnology... Aug 27 2014
    Achillion Pharmaceuticals (ACHN) Surges: Stock Adds 9% in Session Aug 27 2014
    Achillion Pharmaceuticals (ACHN) Stock Hits New One-Year High Aug 26 2014
    US STOCKS-Wall St rises, Dow and S&P 500 set intraday records Aug 26 2014
    US STOCKS-Wall St rises, Dow and S&P 500 set intraday records Aug 26 2014
    3 Biotechs Surging Following InterMune Takeover Aug 26 2014
    'Fast Money' Recap: Next Stop, S&P 2,100? Aug 26 2014
    [video] $8.3 billion biotech deal Aug 25 2014
    Biotech Bounce Gets More Fuel From InterMune Deal Aug 25 2014
    Why Achillion Pharmaceuticals (ACHN) Stock Hit a One-Year High Today Aug 25 2014
    Achillion Attains 52-Week High on ACH-3102 Patent Protection Aug 21 2014
    Biotechnology Stocks to Keep an Eye On Aug 20 2014
    Why Achillion Pharmaceuticals (ACHN) Stock Is Up in After-Hours Trading Today Aug 19 2014
    Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors Aug 19 2014
    Can The Uptrend Continue for Achillion (ACHN)? Aug 19 2014
    U.S. Stocks Rise on Ukraine Talks as Dollar General Gains Aug 18 2014
    Achillion Pharmaceuticals Aug 18 2014
    Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data Aug 18 2014
    Should Achillion Pharma (ACHN) Be In Your Portfolio Now? Aug 18 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK